Equities analysts expect that NeoGenomics, Inc. (NASDAQ:NEO) will report sales of $99.21 million for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for NeoGenomics’ earnings, with estimates ranging from $98.15 million to $100.39 million. NeoGenomics posted sales of $69.10 million in the same quarter last year, which suggests a positive year-over-year […]